Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 260

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 260
---
 effect a business combination within the
completion window which would require FutureTech to liquidate.

Shareholder Vote and Other Actions. The risk that FutureTech Stockholders may object to and challenge the Business Combination and take action
that may prevent or delay the Closing.

Closing Conditions. The fact that completion of the Business Combination is conditioned on the satisfaction of certain closing conditions
that are not within FutureTech’s control.

Litigation.
The possibility of litigation challenging the Business Combination or that an adverse judgment granting permanent injunctive relief could
indefinitely enjoin consummation of the Business Combination.

Fees and Expenses. The fees and expenses associated with completing the Business Combination.

Exercise of Redemption Rights by Public Stockholders. The risk that some or all holders of public shares would exercise their redemption
rights, thereby depleting the amount of cash available to Longevity following the Closing.

Nasdaq Listing.
The potential inability to list post-combination company’s securities on Nasdaq or maintain such listing following the
Closing.

Interests of Certain Persons. FutureTech’s officers and directors may have interests in the Business Combination as individuals that
are in addition to, and that may be different from, the interests of FutureTech’s stockholders generally. For instance, the Sponsor,
and the officers and directors of FutureTech who have invested in the Sponsor entity, will benefit from the completion of a business combination
and may be incentivized to complete an acquisition of a less favorable target company or on terms that would be less favorable to FutureTech
Stockholders. See “Risk Factors” relate to potential conflicts of interest.

Readiness to be a Public Company; Compliance Infrastructure. As Longevity has not previously been a public company, Longevity may not have
all the different types of employees necessary for it to timely and accurately prepare reports for filing with the SEC. There is a risk
that Longevity will not be able to hire the right people to fill in these gaps by the time of the Closing or that additional issues could
arise after the Closing due to its failure to have hired qualified people. In addition, Longevity’s compliance infrastructure may
not be mature enough to be able to keep pace with the increased compliance risks presented by its growth.

Post-Business Combination Corporate Governance. The FutureTech Board considered the corporate governance provisions of
the Merger Agreement and combined company’s anticipated organizational documents and the effect of those provisions on the governance
of FutureTech following the Closing. In particular, they considered that, assuming no redemptions by